Published in N Engl J Med on November 25, 1993
Deep sedation versus general anesthesia in percutaneous edge-to-edge mitral valve reconstruction using the MitraClip system. Clin Res Cardiol (2015) 2.03
Primary angioplasty should be first line treatment for acute myocardial infarction: FOR. BMJ (2004) 1.69
A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J (2007) 1.28
Time as an Adjunctive Agent to Thrombolytic Therapy. J Thromb Thrombolysis (1994) 1.23
Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart (2007) 1.20
Endovascular therapy for ischemic stroke. J Clin Neurol (2015) 1.09
Primary coronary angioplasty for ST-Elevation Myocardial Infarction in Qatar: First nationwide program. Glob Cardiol Sci Pract (2013) 1.08
Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery. Heart (2005) 1.04
New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction. CMAJ (2001) 1.01
The open-artery theory is alive and well--again. N Engl J Med (1993) 1.01
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures. CMAJ (2002) 0.97
A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator. Proc Natl Acad Sci U S A (1999) 0.97
Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart (2003) 0.96
Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am J Respir Cell Mol Biol (2013) 0.94
Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart (2007) 0.92
Comparison of role of early (less than six hours) to later (more than six hours) or no cardiac catheterization after resuscitation from out-of-hospital cardiac arrest. Am J Cardiol (2011) 0.90
Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome. Heart (2005) 0.89
Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction. Am J Transl Res (2015) 0.88
Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care (2017) 0.86
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol (2003) 0.85
Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv Res (2002) 0.85
Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol (2015) 0.85
Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital. Postgrad Med J (2002) 0.83
Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity. J Biomed Sci (2013) 0.83
Rescue PTCA Following Failed Thrombolysis and Primary PTCA: A Retrospective Study of Angiographic and Clinical Outcome. J Thromb Thrombolysis (1997) 0.82
Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol (2008) 0.82
A cluster randomised trial to assess the impact of clinical pathways on AMI management in rural Australian emergency departments. BMC Health Serv Res (2009) 0.81
Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. Appl Environ Microbiol (1998) 0.81
Imaging microvascular obstruction and its clinical significance following acute myocardial infarction. Heart Fail Rev (2006) 0.81
Evaluation of Coronary Artery Status by Coronary Angiography after First Survival of Acute Myocardial Infarction. J Clin Diagn Res (2015) 0.80
Targeted Delivery of VEGF after a Myocardial Infarction Reduces Collagen Deposition and Improves Cardiac Function. Cardiovasc Eng Technol (2012) 0.80
Acute myocardial infarction: reperfusion treatment. Heart (2002) 0.80
Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitro. Inflammation (1997) 0.80
Measuring comorbidity in cardiovascular research: a systematic review. Nurs Res Pract (2013) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
Hirudin in Acute Myocardial Infarction. J Thromb Thrombolysis (1995) 0.79
Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarction. PLoS One (2013) 0.79
Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial). Curr Control Trials Cardiovasc Med (2004) 0.79
Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility study. Can J Cardiol (2006) 0.79
Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator. J Thromb Thrombolysis (1998) 0.78
Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction. PLoS One (2014) 0.78
Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary Angioplasty. J Thromb Thrombolysis (1996) 0.78
Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study. Int J Cardiovasc Imaging (2014) 0.77
Prognostic value of Angiographic Perfusion Score (APS) following percutaneous interventions in acute coronary syndromes. Indian Heart J (2012) 0.77
Randomized, Placebo-Controlled Study of Lamifiban with Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: Rationale and Design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Study. J Thromb Thrombolysis (1995) 0.77
'Mechanical thrombectomy alone' as a definite therapy for rescue angioplasty. BMJ Case Rep (2013) 0.77
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial. Heart (2005) 0.77
Optimization of the Expression of Reteplase in Escherichia coli TOP10 Using Arabinose Promoter. Jundishapur J Nat Pharm Prod (2015) 0.77
The effect of Allium sativum on ischemic preconditioning and ischemia reperfusion induced cardiac injury. Indian J Pharmacol (2008) 0.77
Emergency management of acute myocardial infarction. Br J Clin Pharmacol (1999) 0.77
Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT. Eur J Nucl Med Mol Imaging (2007) 0.77
A novel predictor of infarct-related artery patency before percutaneous intervention and in-hospital outcomes for ST-segment elevation myocardial infarction patients: serum bilirubin level. Postepy Kardiol Interwencyjnej (2014) 0.76
A review of cardiogenic shock in acute myocardial infarction. Curr Cardiol Rev (2008) 0.76
An Angiographic Study of Intracoronary Streptokinase versus Intravenous Tissue Plasminogen Activator After Failed Coronary Thrombolysis with Intravenous Streptokinase. J Thromb Thrombolysis (1996) 0.76
Myocardial salvage for ST-elevation myocardial infarction with terminal QRS distortion and restoration of brisk epicardial coronary flow. Heart Vessels (2009) 0.75
Reperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now. BMJ (2000) 0.75
New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications. Vasc Health Risk Manag (2008) 0.75
Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction. Clin Med Insights Cardiol (2016) 0.75
Effect of thrombolytic therapy on the incidence of early left ventricular infarct expansion in acute anterior myocardial infarction. Oman Med J (2011) 0.75
Thrombolytic therapy for myocardial infarction. N Engl J Med (1994) 0.75
Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase? Indian Heart J (2016) 0.75
The concurrent chronic total occlusion in a non-infarct artery strongly associate with poor long-term prognosis in patients with acute myocardial infarction and multivessel coronary disease. Korean Circ J (2012) 0.75
Effect of coronary artery revascularization on in-hospital outcomes and long-term prognoses in acute myocardial infarction patients with prior ischemic stroke. J Geriatr Cardiol (2016) 0.75
Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India. Indian Heart J (2017) 0.75
Non-invasive treatment of ST elevation myocardial infarction. Postgrad Med J (2007) 0.75
Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Asia (2016) 0.75
Thrombolytic therapy for myocardial infarction. N Engl J Med (1994) 0.75
A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction. BMC Cardiovasc Disord (2016) 0.75
Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention. Scientifica (Cairo) (2013) 0.75
Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction. Iran Red Crescent Med J (2014) 0.75
Decrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarction. Int J Biol Sci (2015) 0.75
Clinical pharmacology and therapeutics. BMJ (1995) 0.75
The role of coronary angioplasty and stenting in acute myocardial infarction. Postgrad Med J (1999) 0.75
Improving reperfusion after myocardial infarction. BMJ (1999) 0.75
Effects of streptokinase on reflow in rescue percutaneous coronary intervention. ARYA Atheroscler (2013) 0.75
The effect of door-to-balloon delay in primary percutaneous coronary intervention on clinical outcomes of STEMI: a systematic review and meta-analysis protocol. Syst Rev (2016) 0.75
A comparison of rescue and primary percutaneous coronary interventions for acute ST elevation myocardial infarction. Indian Heart J (2017) 0.75
Detection of acute coronary occlusion in patients with acute coronary syndromes presenting with isolated ST-segment depression. Eur Heart J Acute Cardiovasc Care (2012) 0.75
Effect of serum creatine kinase-MBmass on the early and hierarchical diagnosis of related artery reperfusion in acute myocardial infarction. Postgrad Med J (2007) 0.75
Temporary Transvenous Cardiac Pacing in Patients With Acute Myocardial Infarction Predicts Increased Mortality. Cardiol Res (2012) 0.75
Additional ST-segment elevation during thrombolytic therapy in patients with acute ST-elevation myocardial infarction: impact on myocardial salvage and final infarct size. Wien Klin Wochenschr (2003) 0.75
Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination. J Thromb Thrombolysis (2017) 0.75
Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow. Eur J Nucl Med Mol Imaging (2002) 0.75
The evolution of recombinant thrombolytics: Current status and future directions. Bioengineered (2016) 0.75
Angiographic result of index PCI determines the presence of right ventricular infarction in patients with acute inferior myocardial infarction. Int J Cardiovasc Imaging (2015) 0.75
Time to Treatment: A Crucial Factor in Thrombolysis and Primary Angioplasty. J Thromb Thrombolysis (1996) 0.75